258 related articles for article (PubMed ID: 29113767)
1. Renal Functional Outcome of Partial Nephrectomy for Complex R.E.N.A.L. Score Tumors With or Without Neoadjuvant Sunitinib: A Multicenter Analysis.
McDonald ML; Lane BR; Jimenez J; Lee HJ; Yim K; Bindayi A; Hamilton ZA; Field CA; Bloch AS; Dey S; Noyes S; McKay R; Millard F; Rini BI; Campbell SC; Derweesh IH
Clin Genitourin Cancer; 2018 Apr; 16(2):e289-e295. PubMed ID: 29113767
[TBL] [Abstract][Full Text] [Related]
2. Impact of tumour morphology on renal function decline after partial nephrectomy.
Mehrazin R; Palazzi KL; Kopp RP; Colangelo CJ; Stroup SP; Masterson JH; Liss MA; Cohen SA; Jabaji R; Park SK; Patterson AL; L'Esperance JO; Derweesh IH
BJU Int; 2013 Jun; 111(8):E374-82. PubMed ID: 23714649
[TBL] [Abstract][Full Text] [Related]
3. Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma.
Lane BR; Derweesh IH; Kim HL; O'Malley R; Klink J; Ercole CE; Palazzi KL; Thomas AA; Rini BI; Campbell SC
Urol Oncol; 2015 Mar; 33(3):112.e15-21. PubMed ID: 25532471
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Renal Functional Outcomes After Radical or Partial Nephrectomy for Renal Masses ≥7 cm Using the RENAL Score.
Kopp RP; Liss MA; Mehrazin R; Wang S; Lee HJ; Jabaji R; Mirheydar HS; Gillis K; Patel N; Palazzi KL; Wan JY; Patterson AL; Derweesh IH
Urology; 2015 Aug; 86(2):312-9. PubMed ID: 26189330
[TBL] [Abstract][Full Text] [Related]
5. Partial nephrectomy vs. radical nephrectomy for stage I renal cell carcinoma in the presence of predisposing systemic diseases for chronic kidney disease.
Demir Ö; Bozkurt O; Çelik S; Çömez K; Aslan G; Mungan U; Çelebi İ; Esen A
Kaohsiung J Med Sci; 2017 Jul; 33(7):339-343. PubMed ID: 28738974
[TBL] [Abstract][Full Text] [Related]
6. A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma.
Rini BI; Plimack ER; Takagi T; Elson P; Wood LS; Dreicer R; Gilligan T; Garcia J; Zhang Z; Kaouk J; Krishnamurthi V; Stephenson AJ; Fergany A; Klein EA; Uzzo RG; Chen DY; Campbell SC
J Urol; 2015 Aug; 194(2):297-303. PubMed ID: 25813447
[TBL] [Abstract][Full Text] [Related]
7. Robotic unclamped "minimal-margin" partial nephrectomy: ongoing refinement of the anatomic zero-ischemia concept.
Satkunasivam R; Tsai S; Syan S; Bernhard JC; de Castro Abreu AL; Chopra S; Berger AK; Lee D; Hung AJ; Cai J; Desai MM; Gill IS
Eur Urol; 2015 Oct; 68(4):705-12. PubMed ID: 26071789
[TBL] [Abstract][Full Text] [Related]
8. Will the kidney function be reduced in patients with renal cell carcinoma following laparoscopic partial nephrectomy? Baseline eGFR, warm ischemia time, and RENAL nephrometry score could tell.
Wang Z; Liu C; Chen R; Liu S; Feng C; Yu K; Zeng X
Urol Oncol; 2018 Nov; 36(11):498.e15-498.e24. PubMed ID: 30241952
[TBL] [Abstract][Full Text] [Related]
9. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
10. Kidney function following partial or radical nephrectomy for renal cell carcinoma: a population-based study.
Mariusdottir E; Jonsson E; Marteinsson VT; Sigurdsson MI; Gudbjartsson T
Scand J Urol; 2013 Dec; 47(6):476-82. PubMed ID: 23597159
[TBL] [Abstract][Full Text] [Related]
11. Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting.
Long JA; Bernhard JC; Bigot P; Lanchon C; Paparel P; Rioux-Leclercq N; Albiges L; Bodin T; Nouhaud FX; Boissier R; Gimel P; Méjean A; Masson-Lecomte A; Grenier N; Cornelis F; Grassano Y; Comat V; Le Clerc QC; Rigaud J; Salomon L; Descotes JL; Sengel C; Roupret M; Verhoest G; Ouzaid I; Arnoux V; Bensalah K;
World J Urol; 2017 Apr; 35(4):649-656. PubMed ID: 27498139
[TBL] [Abstract][Full Text] [Related]
12. [Perioperative outcomes and mid-term results of radiofrequency ablation and partial nephrectomy in indications of renal tumor treatment and imperative nephron-sparing procedure].
Arnoux V; Descotes JL; Sengel C; Terrier N; Rambeaud JJ; Long JA
Prog Urol; 2013 Feb; 23(2):99-104. PubMed ID: 23352302
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.
Salem ME; Shah SN; Elson P; Garcia JA; Wood LS; Medsinge A; Campbell S; Dreicer R; Rini BI
Clin Genitourin Cancer; 2014 Apr; 12(2):117-23. PubMed ID: 24126239
[TBL] [Abstract][Full Text] [Related]
14. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
[TBL] [Abstract][Full Text] [Related]
15. Comparison of functional outcomes of robotic and open partial nephrectomy in patients with pre-existing chronic kidney disease: a multicenter study.
Hamilton ZA; Uzzo RG; Larcher A; Lane BR; Ristau B; Capitanio U; Ryan S; Dey S; Correa A; Reddy M; Proudfoot JA; Nasseri R; Yim K; Noyes S; Bindayi A; Montorsi F; Derweesh IH
World J Urol; 2018 Aug; 36(8):1255-1262. PubMed ID: 29532222
[TBL] [Abstract][Full Text] [Related]
16. Preserving Renal Function through Partial Nephrectomy Depends on Tumor Complexity in T1b Renal Tumors.
Yoo S; You D; Jeong IG; Hong B; Hong JH; Kim CS; Ahn H; Song C
J Korean Med Sci; 2017 Mar; 32(3):495-501. PubMed ID: 28145654
[TBL] [Abstract][Full Text] [Related]
17. Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trial.
Karam JA; Devine CE; Fellman BM; Urbauer DL; Abel EJ; Allaf ME; Bex A; Lane BR; Thompson RH; Wood CG
BJU Int; 2016 Apr; 117(4):629-35. PubMed ID: 26033220
[TBL] [Abstract][Full Text] [Related]
18. R-LESS partial nephrectomy trifecta outcome is inferior to multiport robotic partial nephrectomy: comparative analysis.
Komninos C; Shin TY; Tuliao P; Yoon YE; Koo KC; Chang CH; Kim SW; Ha JY; Han WK; Rha KH
Eur Urol; 2014 Sep; 66(3):512-7. PubMed ID: 24275311
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting renal function after open partial nephrectomy-a comparison of clampless and clamped warm ischemic technique.
Kopp RP; Mehrazin R; Palazzi K; Bazzi WM; Patterson AL; Derweesh IH
Urology; 2012 Oct; 80(4):865-70. PubMed ID: 22951008
[TBL] [Abstract][Full Text] [Related]
20. PADRES: a phase 2 clinical trial of neoadjuvant axitinib for complex partial nephrectomy.
Hakimi K; Campbell SC; Nguyen MV; Rathi N; Wang L; Meagher MF; Rini BI; Ornstein M; McKay RR; Derweesh IH
BJU Int; 2024 Apr; 133(4):425-431. PubMed ID: 37916303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
